Johns Hopkins
Baltimore, Maryland 94117
39 studies enrolling now · 225 studies all time
What they study most
Acute Disseminated Encephalomyelitis, Acute Infection, Acute Lymphoblastic Leukemia (ALL), Acute Myelogenous Leukemia (AML or ANLL), Acute Myeloid Leukemia, Adenovirus, Adherence, Medication, Adherence, Patient, Adherence, Treatment, Adolescent - Emotional Problem, Adolescent Idiopathic Scoliosis, Advanced Angiosarcoma
Studies at this site
- Study of COYA 302 for the Treatment of ALS — Recruiting now
- Multi-Center Clean Air Randomized Controlled Trial in COPD — Recruiting now
- Belimumab With Rituximab for Primary Membranous Nephropathy — Recruiting now
- A Study of TAK-188 in Adults With Advanced or Spreading Solid Tumors — Recruiting now
- SELUTION 4 De Novo Small Vessel IDE Trial — Recruiting now
- Functional Assessment in Liver Transplantation — Recruiting now
- Study of RMC-5127 in Patients With Advanced KRAS G12V-Mutant Solid Tumors — Recruiting now
- Edwards PASCAL Transcatheter Valve Repair System Pivotal Clinical Trial — Recruiting now
- A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs) — Recruiting now
- Anticoagulation for New-Onset Post-Operative Atrial Fibrillation After CABG — Recruiting now
- A Clinical Trial Investigating the Safety and Biological Activity of the Antibody BNT351 in Adults Living Without and With HIV — Recruiting now
- Omalizumab for the Treatment of Food Allergy in Patients With Elevated Total IgE Levels — Recruiting now
- Targeted Alpha-Particle Therapy for Advanced Somatostatin Receptor Type 2 (SSTR2) Positive Tumors — Recruiting now
- Evaluation of RBS2418 in Combination With Tremelimumab Plus Durvalumab in Participants With Advanced Unresectable Hepatocellular Carcinoma — Recruiting now
- A Trial to Evaluate CSF ctDNA and Safety of Plixorafenib Alone or With Retifanlimab in Patients With BRAF-altered Glioma — Recruiting now
- Treatment of Refractory BK Infections With Related Donor BK Specific Cytotoxic T-cells (CTLs) — Recruiting now
- Leveraging Technology to Improve Medication Adherence in Youth With Kidney or Liver Transplant — Recruiting now
- The EMPOWER Trial - The Carillon Mitral Contour System® in Treating Heart Failure With FMR — Recruiting now
- A Study of Assessment on Safety and Effectiveness of BWI Pulsed Field Ablation With OMNYPULSE Catheter for the Treatment of Paroxysmal Atrial Fibrillation (PAF) — Recruiting now
- Multi-Institutional Registry for Malignant Peripheral Nerve Sheath Tumors — Recruiting now
- Psychedelic Healing: Adjunct Therapy Harnessing Opened Malleability — Recruiting now
- First-in-human Trial of STC-1010, an Immunotherapy, in Patients With Unresectable Locally Advanced or Metastatic Colorectal Cancer — Recruiting now
- Estrogen Supplementation and Bone Health in Women With CF — Recruiting now
- The Natural History of TRPV4 Neuropathy — Recruiting now
- Sildenafil for Early Pulmonary Vascular Disease in Scleroderma — Recruiting now
- Clinical Trial Evaluating the Efficacy and Safety of AGB101 for Treatment of Parkinson's Disease Related Psychosis — Recruiting now
- Abatacept in Immune Checkpoint Inhibitor Myocarditis — Recruiting now
- Effectiveness of the WearME System for COPD Severity and Respiratory Function — Recruiting now
- Virus Specific Cytotoxic T-Lymphocytes (CTLs) for Refractory Cytomegalovirus (CMV) — Recruiting now
- EBV-specific Cytotoxic T-lymphocytes (CTLs) for Refractory EBV Infection — Recruiting now
- Adenovirus-specific Cytotoxic T-lymphocytes for Refractory Adenovirus Infection — Recruiting now
- Parkinson's Foundation PD GENEration Genetic Registry — Recruiting now
- A Trial of AMXI-5001 for Treatment in Patients With Advanced Malignancies — Recruiting now
- Study of Rituximab or Tocilizumab for Patients With Steroid-Dependent Immune-Related Adverse Events (irAEs) — Running, not enrolling
- A Study to Evaluate the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of Satralizumab in Participants With Myelin Oligodendrocyte Glycoprotein Antibody-associated Disease — Running, not enrolling
- Expanded Access Program for Daraxonrasib (RMC-6236) in Previously Treated Metastatic Pancreatic Adenocarcinoma — Available (expanded access)
- Olaparib Treatment in BRCA Mutated Ovarian Cancer Patients After Complete or Partial Response to Platinum Chemotherapy — Running, not enrolling
- Remote Monitoring in Progressive Supranuclear Palsy (PSP) — Starting soon
- Study of INBRX-109 in Conventional Chondrosarcoma — Running, not enrolling
- Pre-op Pembro + Radiation Therapy in Breast Cancer (P-RAD) — Running, not enrolling
- AAA-SHAPE Pivotal Trial: Abdominal Aortic Aneurysm Sac Healing and Prevention of Expansion — Running, not enrolling
- Safe Spaces 4 Sexual Health — Completed
- A Study of Nasal Foralumab in Non-Active Secondary Progressive Multiple Sclerosis Patients — Running, not enrolling
- The PRECISION Trial (Profiling Early Breast Cancer for Radiotherapy Omission): A Phase II Study of Breast-Conserving Surgery Without Adjuvant Radiotherapy for Favorable-Risk Breast Cancer — Running, not enrolling
- Water Vapor Ablation for Localized Intermediate Risk Prostate Cancer — Running, not enrolling
- Retinal Atrophy and Neurofilament Light Chain in People With Multiple Sclerosis Taking Ofatumumab — Enrolling by invitation
- An Efficacy, Safety, Tolerability, Immunogenicity, and Lot-Consistency Clinical Trial of a 6-Valent OspA-Based Lyme Disease Vaccine (VLA15) — Completed
- Phase 3 Study of Daraxonrasib (RMC-6236) in Patients With Previously Treated Metastatic Pancreatic Ductal Adenocarcinoma (PDAC) — Running, not enrolling
- Circumferential Vertebral Reconstruction of Osteoporotic Compression Fractures Using a Novel Bipedicular Peek Implant — Stopped early
- Risk Enabled Therapy After Initiating Neoadjuvant Chemotherapy for Bladder Cancer (RETAIN) — Completed